Cobroxin to be featured on morning talk show

DELRAY BEACH, Fla. XenaCare announced Wednesday that its over-the-counter pain reliever, Cobroxin, will be featured on a segment of "The Balancing Act," a morning show that airs on Lifetime Television.

“As the only morning show in the United States dedicated specifically to educating, inspiring and empowering women, 'The Balancing Act' reaches an important segment of Cobroxin consumers,” stated Frank Rizzo, president and CEO of XenaCare. “We look forward to working closely with 'The Balancing Act's' hosts, Beth Troutman and Kristy Villa, to help continue to educate viewers about Cobroxin and its added benefits over traditional pain relievers.” he concluded.

Cobroxin contains minute quantities of cobra venom — manufactured in accordance with the Homeopathic Pharmacopeia of the U.S. — as its active ingredient.

The segment is slated to air May 17 and May 31 and will feature an interview with Rik Deitsch, chairman and CEO of Nutra Pharma Corporation, the company that developed and currently manufactures Cobroxin.

Cobroxin currently is available as an advanced oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and also is available as an advanced topical gel for treating joint pain and pain associated with repetitive stress and arthritis, the company stated.

Login or Register to post a comment.